Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta

European Journal of Pharmacology

Volumn 377, Issue 2-3, 1999, Pages 209-214

  Pu, Qian ^a   Bordet, Régis ^a   Robin, Emmanuel ^b   Puisieux, François ^a   Vallet, Benoit ^b   Dupuis, Bernard ^a  

^a Faculty of Medicine   (France)

^b CH and U de Lille   (France)

Author keywords

Aortic ring; Endothelium; Lipopolysaccharide; N( ) monomethyl L arginine; Vasorelaxation

Indexed keywords

ACETYLCHOLINE; CALCIMYCIN; INDOMETACIN; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INDOMETHACIN; LIPOPOLYSACCHARIDES; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PHENYLEPHRINE; RATS; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032791813     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00420-3     Document Type: Article

References (27)

1. Amrani M., Corbett J., Allen N.J., O'Shea J., Boateng S.Y., May A.J., Dunn M.J., Yacoub M.H. Induction of heart-shock proteins enhances myocardial and endothelial functional recovery after prolonged cardioplegic arrest. Ann. Thorac. Surg. 57:1994;157-160.
2. Bolli R., Manchikalapudi S., Tang X.L., Takano H., Qiu Y., Guo Y., Zhang Q., Jadoon A.K. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Circ. Res. 81:1997;1094-1107.
3. Brown J.M., Grosso M.A., Terada L.S., Whitman G.J.R., Banerjee A., White C.W., Harken A.H., Repin J.E. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemic-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2516-2620.
4. Busse R., Mülsch A., Fleming I., Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation. 87:1993;18-25. suppl V.
5. Chen J., Simon R. Ischemic tolerance in the brain. Neurology. 48:1997;306-311.
6. Deplanque D., Bordet R., Puisieux F., Leys D., Dupuis B. Delayed neuroprotective effect of low doses of bacterial lipopolysaccharide in transient focal cerebral ischaemia in rats. Br. J. Pharmacol. 122:1997;323P.
7. Dudek R., Kibira S., Kahler J., Bing R.J. The effect of immune mediators (cytokines) on the release of endothelium-derived relaxing factor (EDRF) and of prostacyclin by freshly harvested endothelial cells. Life Sci. 50:1992;863-873.
8. Elliott G.T. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 30:1998;3-17.
9. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
10. G-monomethyl-L-arginine or indomethacin. J. Pharmacol. Exp. Ther. 272:1995;452-459.
11. Huang K., Kuo L., Liao J.C. Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase. Biochem. Biophys. Res. Commun. 245:1998;33-37.
12. Julou-Schaeffer G., Gray G.A., Fleming I., Schoot C., Parratt J.R., Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259:1990;H1038-H1043.
13. Kim S.J., Ghaleh B., Kudej R.K., Huang C.H., Hintze T.H., Vatner S.F. Delayed enhanced nitric oxide-mediated coronary vasodilation following brief ischemia and prolonged reperfusion in conscious dogs. Circ. Res. 81:1997;53-59.
14. Kroll J., Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252:1998;743-746.
15. Liu S.F., Adcock I.M., Old R.W., Barnes P.J., Evans T.W. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit. Care Med. 24:1996;1219-1225.
16. Lu J.L., Schmiege L.M., Kuo L., Kiao J.C. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem. Biophys. Res. Commun. 225:1996;1-5.
17. Meurice T., Bauters C., Auffray J.L., Vallet B., Hamon M., Valero F., Van Belle E., Lablanche J.M., Bertrand M.E. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation. 93:1996;18-22.
18. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
19. Mugge A., Elwell J.H., Peterson T.E., Harrison D.G. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am. J. Physiol. 260:1991;C219-C225.
20. Myers P.R., Zhong Q., Jones J.J., Tanner M.A., Adams H.R., Parker J.L. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am. J. Physiol. 268:1995;H955-H961.
21. Parratt J.R., Szekeres L. Delayed protection of the heart against ischaemia. Trends Pharmacol. Sci. 16:1995;351.
22. Richard V., Kaeffer N., Tron C., Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation. 89:1994;1254-1261.
23. Richard V., Kaeffer C., Artigues C., Henry J.P., Thuillez C. Prior heart stress increases endothelium-dependent relaxations of rat isolated arteries. Br. J. Pharmacol. 122:1997;197P.
24. Salvemini D., Korbut R., Anggard E., Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 87:1990;2593-2597.
25. Song W., Furman B.L., Parrat J.R. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br. J. Pharmacol. 118:1996;2157-2163.
26. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748:1997;267-270.
27. Zhao L., Weber P.A., Smith J.R., Comerford M.L., Elliott G.T. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J. Mol. Cell. Cardiol. 29:1997;1567-1576.